The top two positions in the S&P 500 gainers were eliminated due to pending mergers. Hospira Inc. (NYSE: HSP) was the top performing S&P 500 stock with a 43.5% gain so far this year, but Pfizer Inc. (NYSE: PFE) is acquiring Hospira for …
HSP) for more than $15 billion. In morning trading Thursday, the Dow Jones Industrial Average, which measures the …
Looking for a stock that might be in a good position to beat earnings at its next report? Consider Hospira Inc. (HSP), a firm in the Medical Products industry, which could be a great candidate for another beat. This company has seen a nice …
Management will buy-back stock. The company has $2.00 per share in earnings now and in a year it will have $3 per share. A fifteen multiple (conservative given the business and competing investments) gives you $45. Hospira, Inc. …
February 17, 2015 09:40 ET | Source: Shareholders Foundation, Inc. SAN DIEGO, Feb. 17, 2015 (GLOBE NEWSWIRE) …
Hospira Inc. (NYSE: HSP) Raised to Buy at BofA/ML ... Kindred Healthcare, Inc. (NYSE: KND) named as Value stock
Hospira shares closed at $29.81, down nearly 9 percent, on the New York Stock Exchange. The company said it expects the ban to hurt 2013 adjusted earnings by 5 cents to 15 cents per share. Hospira had forecast 2013 adjusted earnings …
(Reuters) - Javelin Pharmaceuticals Inc JAV.A said its board determined that a buyout offer it received from hospital-products and generic drug maker Hospira Inc HSP.N was superior to ... Pharmaceuticals in an all-stock deal worth …
This suggests that analysts have very recently bumped up their estimates for HSP, giving the stock a Zacks Earnings ESP of 5.66% heading into earnings season. Why is this Important? A positive reading for the Zacks Earnings ESP has …
Hospira, Inc. (NYSE:HSP) and Danone SA (ADR) (OTCMKTS:DANOY) (EPA:BN) have been in negotiations for several weeks, and according to people familiar with the developments, the potential cash and stock deal could be worth about …